Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy-Reference-Cited by-同舟云学术

Retrospective analysis of the efficacy of adjuvant CIK cell therapy in epithelial ovarian cancer patients who received postoperative chemotherapy

Published:2018-11-11 Issue:2 Volume:8 Page:e1528411
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Zhou Yun¹²,Chen Chang-long¹³,Jiang Sen-wei¹²,Feng Yanling¹²,Yuan Linjing⁴,Chen Ping¹⁵,Zhang Lan⁶,Huang Shuting¹²,Li Jundong¹²,Xia Jian-Chuan¹⁷,Zheng Min¹²

Affiliation:

1. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

2. Department of Gynecology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

3. Department of Radiation Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China

4. Department of Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P. R. China

5. Department of VIP region, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

6. Department of Radiotherapy, Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University, Kunming, P. R. China

7. Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

Funder

National Natural Science Foundation of China

Science and Technology Plan Program of Guangdong Province

the project of Guangzhou Science and Technology Plan

the project of state key laboratory of oncology in south China

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1528411

Reference47 articles.

1. Cancer statistics, 2015

2. Ovarian Cancer

3. Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

4. Randomized Phase III Trial of Topotecan Following Carboplatin and Paclitaxel in First-line Treatment of Advanced Ovarian Cancer: A Gynecologic Cancer Intergroup Trial of the AGO-OVAR and GINECO

5. Recent progress in the diagnosis and treatment of ovarian cancer

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytokine-induced killer cells: new insights for therapy of hematologic malignancies;Stem Cell Research & Therapy;2024-08-13

2. Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report;Frontiers in Oncology;2024-06-14

3. Optimization of Cytokine-Induced Killer Cell Generation from Mouse Spleen Cells;Drug Targets and Therapeutics;2024-03-31

4. Postoperative therapy for local-advanced gastric cancer: A systematic review and meta-analysis;Advances in Clinical and Experimental Medicine;2023-12-12

5. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22